Clinical trial
Garlic in Hyperlipidemia Caused by HAART
NCT00029250 · National Center for Complementary and Integrative Health (NCCIH), NIH · Withdrawn
Key facts
| NCT number | NCT00029250 |
|---|---|
| Title | Garlic in Hyperlipidemia Caused by HAART |
| Official title | Phase II, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study on the Effects of Garlic on Hyperlipidemia Induced by HAART in HIV-positive Individuals |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Hypercholesterolemia, Hypertriglyceridemia, Hyperglycemia |
| Intervention type | Drug |
| Interventions | Garlic powder standardized to allicin |
| Enrollment | 0 |
| Start date | Nov 1, 2001 |
| Primary completion | May 1, 2003 |
| Completion | May 1, 2003 |
| First posted | Jan 10, 2002 |
| Last update posted | Mar 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: